Skip to main content
Clinical Trials/CTRI/2012/07/002834
CTRI/2012/07/002834Recruiting未知

The Role of Quantitative Sensory Testing in Asymptomatic Diabetic Neuropathy and its relationship with HbA1c.

A0 sites86 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
A
Enrollment
86

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • 1. Age 18 and above.
  • 2. Diabetic patients who underwent Quantitative Sensory Testing (QST).

Exclusion Criteria

  • 1. Patients with known vitamin B12 deficiency, chronic inflammatory polyneuropathy.
  • 2. Patients taking neurotoxic drugs (cytotoxic drugs, isoniazid, metronidazole, chloramphenicol, nitrofurantoin, amiodarone, phenytoin, simvastatin).
  • 3. Patients who present with heavy alcohol abuse (12), >=75 g daily.
  • 4. Patients with known vasculitis.
  • 5. Patients with known heavy metal poisoning.
  • 6. Patients suffering from cancer or on chemotherapy.
  • 7. Patients with severe chronic kidney disease based on clinical findings.

Investigators

Sponsor
A

Similar Trials